<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
    <channel>
        <itunes:owner>
            <itunes:name>eXoZymes</itunes:name>
            <itunes:email>lasse.g@exozymes.com</itunes:email>
        </itunes:owner>
        <title>eXoZymes</title>
        <link>https://exozymes.twentythree.com</link>
        <description></description>
        <language>en-us</language>
        <generator>Visualplatform</generator>
        <docs>http://blogs.law.harvard.edu/tech/rss</docs>
        <itunes:author>eXoZymes</itunes:author>
        <itunes:type>episodic</itunes:type>
        <itunes:explicit>no</itunes:explicit>
        <itunes:image href="https://exozymes.twentythree.com/files/rv0.0/sitelogo.gif"/>
        <image>
            <url>https://exozymes.twentythree.com/files/rv0.0/sitelogo.gif</url>
            <title>eXoZymes</title>
            <link>https://exozymes.twentythree.com</link>
        </image>
        <atom:link rel="self" href="https://exozymes.twentythree.com/rss/tag/jim bowie"/>
        <atom:link rel="next" href="https://exozymes.twentythree.com/rss/tag/jim bowie?tag=jim+bowie&amp;p=2&amp;podcast%5fp=f&amp;https="/>
        <item>
            <enclosure url="http://exozymes.twentythree.com/64968561/100951904/b84ec0d789f34490d6fac2a00e33164c/video_medium/the-story-of-exozymes-interview-video.mp4?source=podcast" type="video/mp4" length="30471133"/>
            <title>The story of eXoZymes: Interview with Tyler Korman and Paul Opgenorth</title>
            <link>http://exozymes.twentythree.com/the-story-of-exozymes-interview</link>
            <description>&lt;p&gt;&lt;p&gt;Interviews with eXoZymes co-founders, Tyler Korman, PhD - and - Paul Opgenorth, PhD, sharing how the basic idea - liberating the enzymes from the confines of working in cells - was hatched in Jim Bowie's lab at UCLA, before being spun out as Invizyne Technologies in 2019 (rebranded to eXoZymes in 2025), including some of the projects and challenges along the way.&lt;/p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://exozymes.twentythree.com/the-story-of-exozymes-interview"&gt;&lt;img src="http://exozymes.twentythree.com/64968561/100951904/b84ec0d789f34490d6fac2a00e33164c/standard/download-45-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</description>
            <guid>http://exozymes.twentythree.com/photo/100951904</guid>
            <pubDate>Wed, 22 May 2024 16:33:18 GMT</pubDate>
            <media:title>The story of eXoZymes: Interview with Tyler Korman and Paul Opgenorth</media:title>
            <itunes:summary>Interviews with eXoZymes co-founders, Tyler Korman, PhD - and - Paul Opgenorth, PhD, sharing how the basic idea - liberating the enzymes from the confines of working in cells - was hatched in Jim Bowie's lab at UCLA, before being spun out as Invizyne Technologies in 2019 (rebranded to eXoZymes in 2025), including some of the projects and challenges along the way.</itunes:summary>
            <itunes:subtitle>Interviews with eXoZymes co-founders, Tyler Korman, PhD - and - Paul Opgenorth, PhD, sharing how the basic idea - liberating the enzymes from the confines of working in cells - was hatched in Jim Bowie's lab at UCLA, before being spun out as...</itunes:subtitle>
            <itunes:author>eXoZymes</itunes:author>
            <itunes:duration>06:56</itunes:duration>
            <media:description type="html">&lt;p&gt;&lt;p&gt;Interviews with eXoZymes co-founders, Tyler Korman, PhD - and - Paul Opgenorth, PhD, sharing how the basic idea - liberating the enzymes from the confines of working in cells - was hatched in Jim Bowie's lab at UCLA, before being spun out as Invizyne Technologies in 2019 (rebranded to eXoZymes in 2025), including some of the projects and challenges along the way.&lt;/p&gt;&lt;/p&gt;&lt;p&gt;&lt;a href="http://exozymes.twentythree.com/the-story-of-exozymes-interview"&gt;&lt;img src="http://exozymes.twentythree.com/64968561/100951904/b84ec0d789f34490d6fac2a00e33164c/standard/download-45-thumbnail.jpg" width="75" height=""/&gt;&lt;/a&gt;&lt;/p&gt;</media:description>
            <media:content url="https://exozymes.twentythree.com/v.ihtml/player.html?token=b84ec0d789f34490d6fac2a00e33164c&amp;source=podcast&amp;photo%5fid=100951904" width="625" height="352" type="text/html" medium="video" duration="416" isDefault="true" expression="full"/>
            <media:thumbnail url="http://exozymes.twentythree.com/64968561/100951904/b84ec0d789f34490d6fac2a00e33164c/standard/download-45-thumbnail.jpg" width="75" height=""/>
            <itunes:image href="http://exozymes.twentythree.com/64968561/100951904/b84ec0d789f34490d6fac2a00e33164c/standard/download-45-thumbnail.jpg/thumbnail.jpg"/>
            <category>cannabinoids</category>
            <category>founder</category>
            <category>interview</category>
            <category>invizyne</category>
            <category>isobutanol</category>
            <category>jim bowie</category>
            <category>paul opgenorth</category>
            <category>SAF</category>
            <category>sustainable aviation fuel</category>
            <category>tyler korman</category>
        </item>
    </channel>
</rss>
